US Patent 8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof

Patent 8013144 was granted and assigned to Chang Gung University on September, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Chang Gung University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8013144

Patent Inventor Names

Yu-Sun Chang0

Lih-Chyang Chen0

Date of Patent

September 6, 2011

Patent Application Number

12484823

Date Filed

June 15, 2009

Patent Primary Examiner

‌

Kimberly Chong

Patent abstract

The present invention discloses an hnRNP K expression-inhibiting compound and a siRNA sequence thereof, wherein a siRNA sequence partially or completely complementary to the sequence of hnRNP K is used to inhibit hnRNP K expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API